ReviewUrologie (Heidelberg, Germany)2026
[Primary vesicoureteral reflux in childhood : Diagnostics, risk stratification and treatment].
Review in Urologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary vesicoureteral reflux (VUR) is a common urological condition in childhood. It is caused by a congenital valve mechanism insufficiency resulting from a shortened submucosal ureter. This leads to retrograde urine flow into the ureter and kidneys and increases the risk of recurrent febrile urinary tract infections (UTI) and renal parenchymal scarring. The International Reflux Study Group classifies VUR into five degrees of severity. The diagnostics focus on basic diagnostics and instrumental reflux testing after risk stratification. A risk-adapted conservative strategy has become the standard treatment as low degrees of reflux often resolve spontaneously. The aim of VUR treatment is to prevent renal scarring and renal dysfunction. Antibacterial prophylaxis may be indicated in selected children. In cases of severe or treatment-resistant symptomatic VUR, endoscopic, laparoscopic/robotic-assisted or open surgical procedures with the corresponding indications should be discussed.
Indexed as
Identifiers
41961298What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.